Endpoints News ٣١ مارس ٢٠٢٦ PepGen’s muscle disease program posts poor mid-stage results as one patient's data get markedly worse
Endpoints News ٣١ مارس ٢٠٢٦ ViiV R&D head Kimberly Smith heads to retirement after three decades in HIV care
Endpoints News ٣٠ مارس ٢٠٢٦ Samsung Bio union workers threaten strike over pay, disclosure of employee data
Endpoints News ٣٠ مارس ٢٠٢٦ Post-Hoc Live: Will MAHA vaccine policies be a political problem for Republicans?
Endpoints News ٣٠ مارس ٢٠٢٦ Viridian’s autoimmune eye disease shot passes Phase 3, but can it compete?
Endpoints News ٣٠ مارس ٢٠٢٦ #ACC26: Kardigan's repeat dosing of blood pressure drug has no benefit over single shot
Endpoints News ٣٠ مارس ٢٠٢٦ #AAD26: Sanofi reports underwhelming Phase 3 OX40 data in eczema, second case of Kaposi’s sarcoma
Endpoints News ٢٩ مارس ٢٠٢٦ #ACC26: Merck leans toward lower Winrevair dose in Phase 3 trial for rare form of heart failure